Huirong Pan

Xiamen, 361022, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China.

Post-Marketing Safety Surveillance of Autoimmune Diseases Following Bivalent Human Papillomavirus Vaccination in China.

Journal: Vaccines

Published: June 09, 2026

Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years).

Hepatitis E virus seroprevalence in South Africa: a multi-site study among HIV-negative and HIV-positive adults and age-stratified children (2-17 Years).

Journal: BMC infectious diseases

Published: May 04, 2026

Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China.

Immunogenicity and safety of HepE Hecolin® in chronic hepatitis B patients at clinically stable stage: An open-label study in China.

Journal: Human vaccines & immunotherapeutics

Published: January 11, 2025

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)

Published: July 21, 2023

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial.

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial.

Journal: Emerging microbes & infections

Published: March 06, 2023

Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study.

Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study.

Journal: The Lancet regional health. Western Pacific

Published: February 24, 2021

Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages.

Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages.

Journal: Vaccine

Published: March 26, 2020

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal.

Capsid destabilization and epitope alterations of human papillomavirus 18 in the presence of thimerosal.

Journal: Journal of pharmaceutical analysis

Published: February 10, 2020

Simultaneous in situ visualization and quantitation of dual antigens adsorbed on adjuvants using high content analysis.

Simultaneous in situ visualization and quantitation of dual antigens adsorbed on adjuvants using high content analysis.

Journal: Nanomedicine (London, England)

Published: October 12, 2019

Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.

Demonstration of real-time and accelerated stability of hepatitis E vaccine with a combination of different physicochemical and immunochemical methods.

Journal: Journal of pharmaceutical and biomedical analysis

Published: June 05, 2019

Altered antigenicity and immunogenicity of human papillomavirus virus-like particles in the presence of thimerosal.

Altered antigenicity and immunogenicity of human papillomavirus virus-like particles in the presence of thimerosal.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: April 03, 2019

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro.

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro.

Journal: Emerging microbes & infections

Published: June 16, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026